Inhibition of mitogen-activated protein kinase kinase induces apoptosis of human chondrocytes

被引:134
作者
Shakibaei, M
Schulze-Tanzil, G
de Souza, P
John, T
Rahmanzadeh, M
Rahmanzadeh, R
Merker, HJ
机构
[1] Free Univ Berlin, Inst Anat, D-14195 Berlin, Germany
[2] Free Univ Berlin, Dept Trauma Surg, Med Ctr Benjamin Franklin, D-12200 Berlin, Germany
[3] Charite, Trauma & Reconstruct Surg, D-13353 Berlin, Germany
关键词
D O I
10.1074/jbc.M010859200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously have reported that the mitogen-activated protein kinase (MAPK) pathway is stimulated by adhesion of human chondrocytes to anti-beta (1)-integrin antibodies or collagen type II in vitro. These mechanisms most likely prevent chondrocyte dedifferentiation to fibroblast-like cells and chondrocyte death. To investigate whether this pathway plays an essential role for the differentiation, phenotype, and survival of chondrocytes, we blocked mitogen-activated protein kinase/extracellular signal-regulated kinase (Erk) (MEK), a kinase upstream of the kinase Erk by using U0126, Exposure of chondrocytes to U0126 caused activation of caspase-3 in a dose-dependent manner, Western blot analysis with an antibody specific for dually phosphorylated Erk shows that collagen type II induced phosphorylation of Erkl/2 was specifically blocked by U0126 in a dose-dependent manner. Immunohistochemical analysis showed that treated chondrocytes were caspase-3 positive. In treated chondrocytes, the cleavage of 116-kDa poly(ADP-ribose)polymerase resulted in the 85-kDa apoptosis-related cleavage fragment and was associated with caspase-3 activity, Analysis by electron microscopy showed typical morphological signs of apoptosis, such as crescent-shaped clumps of heterochromatin, and a degraded' pericellular matrix. Thus, these results indicate that the MEK/Erk signal transduction pathway is involved in the maintenance of chondrocytes differentiation and survival. These data stimulate further investigations on the role of mitogen-activated protein kinase pathways in human chondrocytes.
引用
收藏
页码:13289 / 13294
页数:6
相关论文
共 50 条
[31]   TNF-induced signaling in apoptosis [J].
Rath, PC ;
Aggarwal, BB .
JOURNAL OF CLINICAL IMMUNOLOGY, 1999, 19 (06) :350-364
[32]   OSTEOGENIC DIFFERENTIATION OF HYPERTROPHIC CHONDROCYTES INVOLVES ASYMMETRIC CELL DIVISIONS AND APOPTOSIS [J].
ROACH, HI ;
ERENPREISA, J ;
AIGNER, T .
JOURNAL OF CELL BIOLOGY, 1995, 131 (02) :483-494
[33]   Intact cell evidence for the early synthesis, and subsequent late apopain-mediated suppression, of poly(ADP-ribose) during apoptosis [J].
Rosenthal, DS ;
Ding, RC ;
SimbulanRosenthal, CMG ;
Vaillancourt, JP ;
Nicholson, DW ;
Smulson, M .
EXPERIMENTAL CELL RESEARCH, 1997, 232 (02) :313-321
[34]   Detection of pro-caspase-3 in cytosol and mitochondria of various tissues [J].
Samali, A ;
Zhivotovsky, B ;
Jones, DP ;
Orrenius, S .
FEBS LETTERS, 1998, 431 (02) :167-169
[35]   Different cleavage pattern for poly(ADP-ribose) polymerase during necrosis and apoptosis in HL-60 cells [J].
Shah, GM ;
Shah, RG ;
Poirier, GG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (03) :838-844
[36]   Integrin expression and collagen type II implicated in maintenance of chondrocyte shape in monolayer culture: An immunomorphological study [J].
Shakibaei, M ;
DeSouza, P ;
Merker, HJ .
CELL BIOLOGY INTERNATIONAL, 1997, 21 (02) :115-125
[37]   Differentiation of mesenchymal LIMB bud cells to chondrocytes in alginate beads [J].
Shakibaei, M ;
DeSouza, P .
CELL BIOLOGY INTERNATIONAL, 1997, 21 (02) :75-86
[38]   Signal transduction by β1 integrin receptors in human chondrocytes in vitro:: collaboration with the insulin-like growth factor-1 receptor [J].
Shakibaei, M ;
John, T ;
de Souza, P ;
Rahmanzadeh, R ;
Merker, HJ .
BIOCHEMICAL JOURNAL, 1999, 342 :615-623
[39]   Regulation of the expression or recruitment of components of the DNA synthesome by poly(ADP-ribose) polymerase [J].
Simbulan-Rosenthal, CM ;
Rosenthal, DS ;
Boulares, AH ;
Hickey, RJ ;
Malkas, LH ;
Coll, JM ;
Smulson, ME .
BIOCHEMISTRY, 1998, 37 (26) :9363-9370
[40]  
STADLER J, 1991, J IMMUNOL, V147, P3915